September 2012

Biotech Industry Calls for Improvements in the EU Regulation on Clinical Trials

At the end of August 2012, BIO Deutschland submitted a statement on the new EU proposal for a regulation on clinical trials (COM(2012) 369 final) to the Federal Ministry of Health. In the statement, the association called on the ministry to formulate patient safety measures and improvements in patient care using innovative medicinal products in a way that does not exclude innovative small and medium-sized enterprises (iSMEs) from the market.


BIO Deutschland Opposes Further Discrimination against Innovation Funding

In a statement issued on 17 August 2012, BIO Deutschland urged the Federal Ministry of Finance to allow investments in innovations in its bill on implementing the Alternative Investment Funds Managers Directive (2011/61/EU) (the Act Implementing the AIFM Directive).